Microgenics 0226 - DRI® Barbiturates… | USA MedPremium
DRI® Barbiturates Assay Kit for Clinical Chemistry Analyzers by Microgenics
USAMP#58109516SKU: 0226DRI®
Product Spotlight
Designed for the qualitative and semiquantitative detection of barbiturates in human urine, the DRI® Barbiturate Assay ensures accurate toxicology screening with a 200 ng/mL cutoff calibrator.
Features excellent correlation with GC/MS, providing reliable and consistent results for clinical chemistry analysis.
Optimized for use in various clinical chemistry analyzers, this assay kit simplifies barbiturate detection in a clinical setting.